SEI Investments
KYMR icon

SEI Investments’s Kymera Therapeutics KYMR Stock Holding History

SEI Investments’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21M Sell
10,573
-652
-6% -$56K ﹤0.01% 2206
2026
Q1 		$935K Sell
11,225
-2,031
-15% -$161K ﹤0.01% 2389
2025
Q4 		$1.03M Sell
13,256
-1,990
-13% -$134K ﹤0.01% 2169
2025
Q3 		$863K Buy
15,246
+9,171
+151% +$414K ﹤0.01% 2019
2025
Q2 		$265K Buy
+6,075
New +$209K ﹤0.01% 2458
2024
Q2 		– Sell
-6,930
Closed -$278K – 2691
2024
Q1 		$278K Buy
+6,930
New +$248K ﹤0.01% 2330

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

SEI Investments's KYMR Position: Q2 2026 in Review

SEI Investments reduced its Kymera Therapeutics (KYMR) stake by 5.8% in Q2 2026, selling an estimated $56K and leaving 10,573 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #2206.

SEI Investments first reported a position in KYMR in Q1 2024 and has held it in 6 quarters since. 275 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • SEI Investments held 10,573 shares of Kymera Therapeutics worth $1.21M as of Q2 2026.
  • SEI Investments sold 652 Kymera Therapeutics shares in Q2 2026, an estimated $56K.
  • Kymera Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2206 holding.
  • SEI Investments first reported a position in Kymera Therapeutics in Q1 2024 and has held it in 6 quarters since.
  • 275 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.